Abstract
Lead exposure is a serious public health concern with significant neurological and cellular effects. This chapter examines the effects of lead on brain development, neurotransmitter function, and cellular processes from a neurological and cellular perspective. Lead exposure during critical periods of brain development can result in structural and functional changes in the brain, leading to cognitive and behavioral deficits. Alterations in neurotransmitter function, such as dopamine, serotonin, and glutamate, can contribute to the development of neurological conditions. At the cellular level, lead can interfere with mitochondrial function and oxidative stress, leading to cell death and inflammation. In addition, lead exposure can have long-term effects, contributing to the development of neurological disorders such as Parkinson’s disease and Alzheimer’s disease. While the exact mechanisms of lead toxicity are still being investigated, effective strategies to prevent lead exposure are critical, including reducing lead in the environment, improving screening and remediation efforts, and increasing public awareness of the risks associated with lead exposure.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Lead is a toxic heavy metal that has been used for various industrial purposes for many years. It has been used in various industrial applications, including paint, gasoline, batteries, and solder. Due to its extensive use, it has become a widespread environmental pollutant, posing a significant threat to human health and the ecosystem. It is affecting both humans and animals due to its ability to interfere with biological processes, particularly those related to the nervous system, the immune system, and the cardiovascular system.
In humans, its exposure can cause a range of health problems, depending on the level and duration of exposure. The most significant effects are seen in children, who are more vulnerable to lead’s toxic effects than adults (Lidsky and Schneider 2003). Lead exposure in children can cause developmental delays, behavioral problems, decreased IQ, and an increased risk of neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis (Bellinger 2004; Wu et al. 2020). In adults, lead exposure can cause anemia, high blood pressure, kidney damage, and reproductive problems.
In animals, its exposure has been observed in a variety of animal species, including birds, fish, and mammals. In birds, exposure is causing decreased reproductive success, impaired immune function, and neurological damage. In fish, exposure is a cause for developmental abnormalities, impaired growth, and reduced survival. In mammals, lead exposure has similar effects as those seen in humans, including neurological damage, reproductive problems, and decreased immune function.
The lead exposure to multicellular organisms causes widespread systemic changes in the body ranging from cellular dysfunctions to molecular alterations. The various biochemical processes required for metabolism of carbohydrate, lipids, and proteins are significantly affected. In the present, the chapter cellular and neurological alterations caused by the exposure of lead has been discussed.
2 Lead Exposure in the Environment
Lead is present in the environment in various forms, including soil, air, water, and food. Human exposure to lead occurs through multiple routes, including inhalation of contaminated air, ingestion of contaminated soil or water, and consumption of lead-contaminated food. Industrial activities such as mining, smelting, and battery manufacturing are the primary sources of lead pollution. Additionally, lead-based paints used in houses and buildings can also be a significant source of lead exposure.
3 Adverse Effects of Lead Exposure
Lead toxicity affects many biological systems, including the cellular and neurological systems. Lead toxicity can cause oxidative stress, inflammation, and damage to cellular components such as DNA, proteins, and lipids. The nervous system is particularly vulnerable to lead toxicity, as it can interfere with neurotransmitter signaling, neuronal development, and synaptic function (Atchison 1988) The long-term effects of lead exposure on the nervous system include decreased IQ, developmental delays, and an increased risk of neurological disorders such as Parkinson’s disease and Alzheimer’s disease (Liu et al. 2013; Raj et al. 2021).
4 Mechanisms of Cellular and Neurological Effects
The mechanism by which lead exerts its toxic effects is complex and involves multiple mechanisms, including interference with enzymatic activity, oxidative stress, inflammation, and disruption of ion channels and membrane transporters. The exact mechanisms by which lead causes its toxic effects can vary depending on the specific biological system or process that is affected. Lead also bind to and inhibit enzymes such as delta-aminolevulinic acid dehydratase (ALAD), which plays a critical role in heme synthesis. It generates reactive oxygen species (ROS), which may leads to oxidative stress and damage to cellular components. In the nervous system, lead (Pb) interfere with synaptic transmission and disrupt the balance of calcium ions, lead to excitotoxicity and neuronal death (Mason et al. 2014).
4.1 Lead Effect: Cellular Perspective
4.1.1 Cellular Effects
The cellular perspective of lead effects involves understanding how lead interferes with cellular functions and signaling pathways, leading to cellular dysfunction and damage. Lead can enter cells through various mechanisms, including ion channels, transporters, and receptors. Once inside the cell, lead can bind to and disrupt many cellular components, including enzymes, proteins, and DNA. One of the primary mechanisms by which lead exerts its toxic effects is through the generation of reactive oxygen species (ROS), which can cause oxidative stress and damage to cellular structures (Jomova and Valko 2011). Lead can also interfere with calcium signaling, which plays a crucial role in many cellular processes, including cell growth, differentiation, and apoptosis. Lead can bind to and inhibit calcium channels, leading to altered calcium homeostasis and impaired cellular signaling. This can affect many cellular processes, including the activation of signaling pathways, gene expression, and apoptosis. Another mechanism by which lead exerts its toxic effects is through the disruption of the cytoskeleton, which provides structural support and maintains cellular shape. Lead can interfere with the assembly and stability of microtubules and actin filaments, leading to altered cellular morphology, impaired cellular migration, and altered cellular function. Furthermore, lead can alter cellular signaling pathways, leading to aberrant cellular proliferation, differentiation, and apoptosis. Lead exposure has been associated with the activation of many signaling pathways, including MAPK/ERK, PI3K/Akt, and JAK/STAT pathways, which can contribute to cellular dysfunction and damage.
4.1.2 Cellular Proteins Affected by Lead
Proteins are large, complex molecules that perform various functions within cells, such as catalyzing chemical reactions, transporting molecules, and providing structural support. Lead exposure can affect many different cellular proteins, leading to a range of adverse health effects (Chasapis 2018; GoERING 1993). Here are some cellular proteins that can be affected by lead:
Metallothioneins
Metallothioneins are small, cysteine-rich proteins that are found in a variety of organisms, including humans. They are particularly abundant in the liver and kidneys, where they play an important role in detoxifying heavy metals. Metallothioneins bind to metals like lead and cadmium, sequestering them and preventing them from causing damage to cells and tissues (Bruno et al. 2016).
In humans, there are four different metallothionein isoforms: MT-1, MT-2, MT-3, and MT-4. MT-1 and MT-2 are the most abundant isoforms and are found in most tissues, while MT-3 is primarily expressed in the brain and MT-4 is found in stratified squamous epithelia. Lead exposure can increase the expression of metallothioneins in the body, as a protective mechanism against the toxic effects of lead. However, chronic exposure to lead can deplete the levels of metallothioneins, making the body more susceptible to lead toxicity. Metallothioneins are also used as biomarkers of heavy metal exposure and toxicity, as their levels can be measured in blood and urine samples.
Enzymes: Lead can bind to enzymes and alter their structure and function, inhibiting their ability to catalyze chemical reactions. This can disrupt various cellular processes, such as energy metabolism and DNA synthesis.
Ion channels: Lead can interact with ion channels, which are specialized membrane proteins that allow ions to flow in and out of cells. This can interfere with the normal flow of ions across the cell membrane, disrupting various cellular processes such as signaling and muscle contraction.
Transporters: Lead can interact with transporters, which are membrane proteins that move molecules in and out of cells. This can interfere with the normal transport of essential molecules such as nutrients and neurotransmitters, leading to cellular dysfunction.
Receptors: Lead can interact with receptors, which are proteins on the cell surface that bind to specific molecules and trigger signaling pathways. This can interfere with normal cell signaling and contribute to the development of various diseases.
Structural proteins: Structural proteins provide support and shape to cells, and they also play important roles in cell division, movement, and signaling. Lead can interact with structural proteins, such as microtubules and intermediate filaments, which provide support and shape to cells. This can disrupt the normal structure and function of cells, leading to cellular dysfunction. It can affect various structural proteins in cells, which can lead to cellular dysfunction and adverse health effects. Here are some examples of structural proteins that can be affected by lead:
Microtubules: Microtubules are long, hollow tubes made of protein subunits called tubulin. They play a critical role in maintaining cell shape and supporting cell division, as well as in intracellular transport and signaling. Lead exposure can disrupt microtubule structure and function, leading to impaired cell division and transport.
Intermediate filaments: Intermediate filaments are a diverse group of fibrous proteins that provide mechanical strength to cells and tissues. They are particularly important in cells that are subjected to mechanical stress, such as skin cells and muscle cells. Lead exposure can disrupt intermediate filament structure and function, leading to cellular dysfunction and tissue damage.
Extracellular matrix proteins: The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that surrounds cells and provides structural support. ECM proteins, such as collagen and fibronectin, are important in cell adhesion, migration, and signaling. Lead exposure can disrupt ECM protein synthesis and organization, leading to impaired cell function and tissue integrity.
Cytoskeletal proteins: The cytoskeleton is a dynamic network of protein fibers that provides mechanical support to cells and helps maintain their shape and organization. Cytoskeletal proteins, such as actin and myosin, are particularly important in muscle cells and other cells that require movement. Lead exposure can disrupt cytoskeletal organization and function, leading to impaired cell movement and function.
4.1.3 Interfering with Enzymes
Lead can bind to enzymes and disrupt their normal function. This can lead to metabolic disruptions and affect cellular processes. Lead can bind to the active site of enzymes and inhibit their function, e.g., lead inhibits in vitro creatine kinase and pyruvate kinase activity in brain cortex of rats (Lepper et al. 2010). This can disrupt normal cellular processes that depend on enzymatic activity, such as metabolism and protein synthesis. It can cause changes in the structure of enzymes, which can affect their function. This can lead to the formation of misfolded or dysfunctional enzymes that can be harmful to the cell. Some enzymes require cofactors, such as metal ions or vitamins, to function properly. Lead can interfere with the binding of these cofactors to enzymes, leading to decreased enzymatic activity. It can cause irreversible damage to enzymes, leading to their inactivation. This can result in a loss of enzymatic activity that can have severe consequences for cellular processes (Nemsadze et al. 2009).
4.1.4 Disrupting Ion Channels
Lead can interfere with the function of ion channels, which play a key role in the regulation of cellular processes such as signaling and ion transport. It can disrupt ion channels in several ways, leading to cellular dysfunction. Ion channels are specialized membrane proteins that allow ions to move in and out of cells, playing a critical role in various cellular processes such as signaling and ion homeostasis. Ion channels can be opened or closed by different mechanisms, and lead can interfere with these mechanisms. For example, lead can disrupt the voltage-gating mechanism of ion channels, preventing them from opening or closing properly in response to changes in membrane potential. It can bind to ion channel proteins, altering their structure and function. This can cause the ion channels to become less selective or to conduct ions more slowly, leading to cellular dysfunction. The expression of ion channels could be altered either by increasing or decreasing their expression levels. This can disrupt ion homeostasis and signaling pathways, leading to cellular dysfunction.
Lead can enter cells through a variety of mechanisms, including passive diffusion and active transport. Once inside cells, lead can bind to proteins and interfere with cellular processes. For example, lead can bind to calcium-binding proteins and disrupt intracellular calcium signaling, which can affect cell growth and differentiation (Wani et al. 2015). Lead can also interfere with the transport of other essential metals, such as iron and zinc, leading to further cellular dysfunction.
4.1.5 Disruption of Calcium Signaling
Calcium ions play a critical role in many cellular processes, and lead can interfere with calcium signaling by disrupting the function of calcium channels. This can lead to a range of cellular dysfunctions, including impaired cell signaling and mitochondrial dysfunction (Yang et al. 2020). Calcium ions are involved in the regulation of gene expression, and disruption of calcium channels can alter the expression of genes within cells. This can lead to abnormal cellular function and contribute to the development of various diseases. They play a key role in regulating mitochondrial function, and disruption of calcium channels can lead to impaired mitochondrial function. This can lead to cellular dysfunction and contribute to the development of various diseases. Disruption of calcium channels can lead to excessive accumulation of calcium ions within cells, which can trigger cell death. This can contribute to the development of various diseases, including neurodegenerative diseases (Lee and Freeman 2014) and cardiovascular disease.
4.1.6 Altering Gene Expression
Gene expression refers to the process by which genes are transcribed into RNA and translated into proteins, which play a critical role in various cellular processes (Yang et al. 2018). Lead can alter gene expression within cells, which can affect the synthesis of proteins and other cellular components, leading to a range of health effects. Lead exposure can alter gene expression in various ways, leading to a range of adverse health effects. For example, perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner (Gąssowska et al. 2016). Here are some ways in which lead can alter gene expression:
Epigenetic modifications: Lead exposure can cause epigenetic modifications, which refer to changes in gene expression that are not caused by changes in the DNA sequence itself. These modifications can include DNA methylation and histone modifications and can lead to changes in gene expression that can persist over time. For example, combined exposure of lead and cadmium leads to the aggravated neurotoxicity through regulating the expression of histone deacetylase (Zhou et al. 2020).
Alteration of transcription factors: Lead exposure can alter the activity of transcription factors, which are proteins that regulate gene expression by binding to specific DNA sequences. This can lead to changes in gene expression that can contribute to the development of various diseases.
DNA damage: Lead exposure can cause DNA damage, which can lead to changes in gene expression. This can occur through direct interaction with DNA or indirectly through the generation of reactive oxygen species (ROS), which can cause oxidative damage to DNA.
4.1.7 Disruption of Signaling Pathways
Cell signaling refers to the process by which cells communicate with each other to regulate various cellular processes, such as growth, differentiation, and apoptosis. Here are some ways in which lead can disrupt cell signaling: Lead exposure can disrupt signaling pathways within cells, which can lead to changes in gene expression. For example, lead can interfere with calcium signaling, which plays a critical role in regulating gene expression. Lead exposure can disrupt cell signaling in various ways, leading to a range of adverse health effects.
Disruption of receptor-ligand interactions: Lead exposure can disrupt the interaction between receptors on the cell surface and their ligands, which are molecules that bind to the receptors and trigger signaling pathways. This can interfere with normal cell signaling and contribute to the development of various diseases.
Interference with intracellular signaling pathways : Lead exposure can interfere with intracellular signaling pathways, which are triggered by receptor-ligand interactions and relay information within the cell. This can disrupt normal cellular function and lead to cellular dysfunctions.
Alteration of second messenger signaling: Second messengers are molecules that relay signals from the cell surface to the interior of the cell, where they trigger signaling pathways. Lead exposure can interfere with the production or function of second messengers, which can disrupt normal cell signaling.
Disruption of calcium signaling: Calcium ions play a critical role in many signaling pathways within cells, and lead exposure can disrupt calcium signaling. This can interfere with normal cellular function and contribute to the development of various diseases.
5 Lead Toxicity and Blood Cells
Lead exposure may cause vascular dysfunction in the brain (Olung et al. 2021). Lead toxicity can affect various types of blood cells, including red blood cells, white blood cells, and platelets, which can contribute to a range of adverse health effects. Lead exposure can inhibit the synthesis of heme, a component of hemoglobin, which can lead to decreased production of red blood cells and anemia. Lead can also cause the formation of abnormal hemoglobin molecules, which are less efficient at carrying oxygen than normal hemoglobin. This can further contribute to decreased oxygen delivery to the body’s tissues and the development of anemia. Lead exposure can suppress the production and function of white blood cells, which play a critical role in the immune system’s defense against infections and diseases. This can lead to an increased risk of infections and impaired immune function. It can reduce the number and function of platelets, which are responsible for blood clotting, which can lead to an increased risk of bleeding and bruising. In addition to these effects on blood cells, lead toxicity can also lead to other adverse health effects, including neurological and developmental effects, reproductive and fertility problems, and cardiovascular disease.
6 Lead Toxicity and Hemoglobin
Lead toxicity can affect hemoglobin, the protein in red blood cells that carries oxygen from the lungs to the body’s tissues. Lead exposure can lead to anemia, a condition characterized by a decrease in the number of red blood cells or a decrease in the amount of hemoglobin in the blood. One way that lead exposure can affect hemoglobin is by inhibiting the activity of the enzyme delta-aminolevulinic acid dehydratase (ALAD), which is required for the synthesis of heme, a component of hemoglobin. Without heme, the production of hemoglobin is impaired, leading to decreased oxygen-carrying capacity in the blood and anemia. Lead exposure can also lead to the formation of abnormal hemoglobin molecules, which are less efficient at carrying oxygen than normal hemoglobin. This can further contribute to decreased oxygen delivery to the body’s tissues and the development of anemia.
7 Oxidative Stress
One of the primary cellular effects of lead exposure is oxidative stress. Lead exposure can increase the production of reactive oxygen species (ROS), which can damage cellular components such as lipids, proteins, and DNA. Studies have shown that lead exposure can reduce the activity of antioxidant enzymes, such as superoxide dismutase (SOD) and catalase, which help protect cells against oxidative damage (Flora 2009). In addition, lead exposure can lead to the depletion of glutathione, an important cellular antioxidant (Patrick 2006a, b, c; Gasmi et al. 2022; Paithankar et al. 2021).
8 Inflammation
Lead exposure has also been shown to cause inflammation at the cellular level. Studies have shown that lead exposure can increase the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) (3). This can lead to the activation of immune cells and the recruitment of inflammatory cells to affected tissues. Chronic inflammation can contribute to a variety of diseases, including cardiovascular disease and cancer (Navas-Acien et al. 2007; Taiwo et al. 2018).
9 DNA Damage
Lead exposure has also been linked to DNA damage at the cellular level. Studies have shown that lead exposure can cause single-strand breaks and oxidative damage to DNA (Taiwo et al. 2018). In addition, lead exposure can interfere with DNA repair mechanisms, leading to the accumulation of DNA damage over time. This can increase the risk of mutations and cancer.
10 Suppression of Immune Function
Lead exposure has been shown to have significant effects on immune cells, including both innate and adaptive immune responses. Studies have shown that lead exposure can reduce the number and function of immune cells, such as neutrophils, natural killer cells, and T cells (Dietert et al. 2004; Wang et al. 2015). Lead exposure has also been shown to decrease the production of cytokines, such as interleukin-2 (IL-2), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α), which are important for immune function (Koller and Exon 2001; McElvania Tekippe et al. 2018).
Here are some of the specific effects:
-
(a)
Decreased number and function of immune cells: Lead exposure has been shown to decrease the number and function of various immune cells, such as neutrophils, natural killer cells, and T cells (Dietert et al. 2004; Wang et al. 2015).
-
(b)
Suppressed cytokine production: Lead exposure has also been shown to reduce the production of cytokines, such as interleukin-2 (IL-2), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α), which are important for immune function (Koller and Exon 2001; McElvania Tekippe et al. 2018).
-
(c)
Altered immune cell signaling: Lead exposure can interfere with the signaling pathways involved in the activation and differentiation of immune cells (Ahamed and Siddiqui 2007; Patrick 2006a, b, c). For example, lead exposure can inhibit the activity of the transcription factor nuclear factor-kappa B (NF-κB), which is involved in the regulation of cytokine production and immune cell activation (Luster et al. 1998; Almutairi et al. 2022).
-
(d)
Disrupted immune cell communication: Lead exposure can affect the expression and function of cell surface receptors and signaling molecules, such as toll-like receptors (TLRs), which are involved in the recognition of pathogens and the activation of immune cells (Heo et al. 1996; Rosati et al. 2021). Lead exposure can also affect the production and secretion of signaling molecules, such as chemokines and cytokines, which can disrupt the communication between immune cells.
11 Lead Effect: Neurological Perspective
The nervous system is particularly vulnerable to lead toxicity, as it can cross the blood–brain barrier and accumulate in the brain, where it interferes with neurotransmitter signaling, neuronal development, and synaptic function. Neurological perspective of lead effects include its impact on cognitive and behavioral functions also.
11.1 Neurodevelopmental Effects in Children
Public health officials are concerned about lead exposure, particularly in young children who are more at risk due to greater hand-to-mouth activity and who only absorb about half of an oral dosage of water-soluble lead. The adverse effects of organic lead are far greater than that of inorganic lead since it is lipid soluble and impacts the cell rapidly. According to meta-analyses, children’s IQ scores drop by 2–3 points for every 10 µg/dl increase in blood lead levels, and there is no threshold for lead’s negative effects on IQ. A recent study that focuses on the negative impact of lead on the executive and attention domains of neurobehavioral function has found findings that are similar to these. Complex mechanisms underlie lead’s ability to cause neurotoxicity (Rocha and Trujillo 2019).
11.2 Behavioral and Cognitive Effects in Children and Adults
Lead exposure in early life has long been associated with aggressive, disruptive, and erratic conduct that can lead to scholastic failure and expulsion from school (Byers and Lord 1943).Children who are exposed to lead may experience cognitive and behavioral problems, including hyperactivity, as well as problems with fine motor function, hand–eye coordination, and reaction speed. They may also perform less well on IQ tests.
Lead levels in children’s dentin have been linked to unhelpful classroom behavior (Needleman et al. 1979). Boys aged 7–11 exhibit self-reported correlations between aggression, attentiveness, and delinquency and K-shell X-ray fluorescence (KXRF) measurements of lead in the tibia in addition to teacher and parent reports. A cross-sectional study of 15–24 year olds found that those with blood lead levels between 1.5 and 10 μg/dL were over 8 times more likely to meet the DSM-IV criteria for conduct disorder than those with levels in the lowest detectable range of less than 0.7 μg/dL. (Braun et al. 2008). Children with attention deficit hyperactivity disorder (ADHD) and those exposed to lead have behavioral similarities that are noteworthy (Nigg et al. 2008; Rice 2000). In discrimination reversal measures such the Wisconsin Card Sorting Test, spatial delayed alternation, go-no-go task, distractibility task, and serial reaction tasks, children with ADHD and those exposed to lead show severe impairments (Winneke 2011). Low scores on a variety of achievement tests, impulsivity, deficits in verbal processing, non-verbal thinking, reading, and arithmetic were found to be positively correlated with blood lead levels below 5 μg/dL found in children (Canfield et al. 2003). While comparable low amounts of other hazardous heavy metals, such as mercury and aluminum, are not associated with ADHD-like effects, these effects are visible when blood lead levels are below 10 μg/dL (Ha et al. 2009). Blood lead levels below 5 μg/dL are linked to mixed hyperactive-inattentive ADHD symptoms, according to the DSM-IV. When compared to kids whose lead levels are undetectable, children with lead levels below 5 μg/dL have a more than two times higher chance of being diagnosed with ADHD (Froehlich et al. 2009).
The cumulative nature of lead poisoning in adults showed detrimental effects later in life owing to the leaching of lead from bones overtime. Cognitive diseases such as Alzheimer’s were found to be positively correlated with lead exposure early in life. Research support the idea that early lead exposure has latent cognitive effects that manifest later in life as Alzheimer’s disease (Shih et al. 2007). It has been reported that older persons with blood lead levels of 3.46 μg/dL had tibia lead levels averaging 18.7 μg/g, which was a substantially higher cumulative lead level.
It is important that declines in a variety of cognitive abilities, including as language, processing speed, eye-hand coordination, executive functioning, verbal memory and learning, visual memory, and visuoconstruction, were strongly connected with tibia lead levels but not blood lead levels. Despite the fact that blood lead levels were low, steady state and peak blood lead levels were likely high in order to induce the elevated amounts of lead in bone yet were not recorded.
Adults exposed to increased environmental levels of lead were found to possess lower cognitive test performances like verbal and visual memory, visuospatial ability, attention, and executive functioning (Shih et al. 2007).
11.3 Neuropsychiatric Disorders Associated with Lead Exposure
Various studies have associated lead exposure with multiple psychiatric illnesses like schizophrenia, major depressive disorder, mood, anxiety, and general distress and cognitive development, which is adversely correlated with BLLs (Bouchard et al. 2009).People with blood lead levels > 2.1 g/dL had a 2.3-fold increased chance of meeting DSM-IV criteria for major depressive disorder and a 4.9-fold increased risk of panic disorder compared to people with blood lead levels < 0.7 g/dL. BLLs may be low or zero if assessed over the course of 30–40 days after exposure or absorption because of dispersion to multiple organs, even though bone lead levels may be higher.
11.3.1 Cognitive Effects
Lead exposure can cause cognitive deficits, particularly in children, who are more susceptible than adults. The cognitive effects of lead exposure include decreased IQ scores, impaired attention, memory, and learning abilities. Children with high lead levels may also exhibit behavior problems, including hyperactivity and aggression. These cognitive deficits are thought to result from lead-induced alterations in the developing brain, particularly in the prefrontal cortex, which is responsible for executive functions, attention, and decision-making (Lanphear et al. 2005; Finkelstein et al. 1998).
11.3.2 Behavioral Effects
Lead exposure has also been associated with behavioral abnormalities, including aggression, delinquency, and attention deficit hyperactivity disorder (ADHD). The behavioral effects of lead exposure are thought to result from the disruption of the dopaminergic system, which plays a critical role in reward, motivation, and mood regulation. Lead-induced alterations in the dopaminergic system may contribute to the development of behavioral problems by altering the balance between reward and punishment signals, leading to impulsive and aggressive behavior (Needleman 2004).
11.4 Neurological Mechanisms
Lead exerts its neurotoxic effects by interfering with multiple mechanisms in the nervous system, including neurotransmitter signaling, neuronal development, and synaptic function (Green and Planchart 2018). Lead can bind to and inhibit calcium channels, which are critical for synaptic transmission, leading to impaired neurotransmitter release and altered synaptic plasticity (Maeda et al. 2022). Lead can also disrupt the development of neurons, leading to abnormal neuronal migration and dendritic growth, which can affect the formation of synapses and neuronal circuits. Additionally, lead can generate reactive oxygen species (ROS), which can lead to oxidative stress and damage to cellular components. Oxidative stress can also contribute to the disruption of the blood–brain barrier, leading to the infiltration of immune cells and the production of pro-inflammatory cytokines, which can further exacerbate the neurotoxic effects of lead.
11.4.1 Neurotoxic Effects
The primary mechanisms by which lead causes neurological damage is through its ability to disrupt the function of neurotransmitters, including dopamine, serotonin, and norepinephrine (Savolainen et al. 1998). Lead can interfere with the release, uptake, and metabolism of these neurotransmitters, leading to dysregulation of the nervous system (Guilarte and Miceli 1992; Guilarte et al. 2003).
Another mechanism by which lead causes neurological damage is through its ability to disrupt the development of the nervous system. During critical periods of brain development, lead exposure can interfere with the formation and differentiation of neurons, resulting in permanent structural and functional changes in the brain (Cory-Slechta et al. 1997). Lead can also cause oxidative stress and inflammation in the brain, which can lead to damage to neurons and glial cells. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the ability of the body’s antioxidant defense mechanisms to neutralize them. Lead exposure has been shown to increase ROS production and decrease antioxidant capacity in the brain, leading to oxidative damage (Flora 2009). In addition to these mechanisms, lead can also disrupt the blood–brain barrier, which is a protective barrier that prevents harmful substances from entering the brain. Lead exposure can weaken the blood–brain barrier, allowing lead and other toxins to enter the brain and cause damage (Guilarte and McGlothan 1998).
12 Interventions to Mitigate Lead Toxicity
Several interventions can be implemented to mitigate the adverse effects of lead toxicity. Primary prevention strategies include reducing or eliminating exposure to lead by reducing the use of lead-containing products, implementing environmental regulations, and providing education and awareness programs. Secondary prevention strategies involve identifying and treating individuals with elevated blood lead levels through chelation therapy or other medical interventions. Additionally, various antioxidants and neuroprotective agents have been investigated for their potential to mitigate the effects of lead toxicity on the cellular and neurological systems.
13 Conclusion
Lead toxicity can cause a range of neurological disorders that can have lifelong consequences. These disorders can affect cognitive and behavioral functioning, as well as cause more serious conditions such as seizures and encephalopathy. It is crucial that steps are taken to reduce exposure to lead, particularly in young children who are most vulnerable to its effects. This can include measures such as reducing lead in water and soil, removing lead-based paint from homes, and increasing public awareness of the dangers of lead exposure. By taking these steps, we can work to prevent the neurological disorders caused by lead toxicity and promote healthier outcomes for individuals and communities.
References
Ahamed M, Siddiqui MK (2007) Environmental lead toxicity and nutritional factors. Clin Nutr 26(4):400–408
Almutairi MM, Nadeem A, Ansari MA, Bakheet SA, Attia SM, Albekairi TH, Ahmad SF (2022) Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T+ Itpr3tf/J autistic mouse model. Neurotoxicology 91:340–348
Atchison WD (1988) Effects of neurotoxicants on synaptic transmission: lessons learned from electrophysiological studies. Neurotoxicol Teratol 10(5):393–416
Bellinger DC (2004) Lead. Pediatrics 113(4 Suppl):1016–1022
Bjorklund G, Stejskal V, Urbina MA, Dadar M, Chirumbolo S, Mutter J (2018) Metals and Parkinson’s disease: mechanisms and biochemical processes. Curr Med Chem 25(19):2198–2214
Bouchard MF, Bellinger DC, Weuve J, Matthews-Bellinger J, Gilman SE, Wright RO, Weisskopf MG (2009) Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psych 66(12):1313–1319
Braun JM, Froehlich TE, Daniels JL, Dietrich KN, Hornung R, Auinger P, Lanphear BP (2008) Association of environmental toxicants and conduct disorder in US children: NHANES 2001–2004. Environ Health Perspect 116(7):956–962
Bruno CRN, Risso WE, dos Reis Martinez CB (2016) Lead accumulation and metallothionein content in female rats of different ages and generations after daily intake of Pb-contaminated food. Environ Toxicol Pharmacol 48:272–277
Byers RK, Lord EE (1943) Late effects of lead poisoning on mental development. Am J Dis Child 66(5):471–494
Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP et al (2003) Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348:1517–1526
Chasapis CT (2018) Shared gene-network signatures between the human heavy metal proteome and neurological disorders and cancer types. Metallomics 10(11):1678–1686
Cory-Slechta DA, Brockel BJ, O’Mara DJ (1997) Lead exposure and the central nervous system: neural mechanisms of lead-induced neurotoxicity. Curr Opin Neurol 10(3):193–198
Dietert RR, Lee JE, Hussain I, Piepenbrink MS (2004) Developmental immunotoxicology of lead. Toxicol Appl Pharmacol 198(2):86–94
Finkelstein Y, Markowitz ME, Rosen JF (1998) Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Rev 27(2):168–176
Flora SJ (2009) Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid Med Cell Longev 2(4):191–206
Gasmi A, Noor S, Piscopo S, Menzel A (2022) Toxic metal–mediated neurodegradation: a focus on glutathione and GST gene variants. Arch Razi Instit 77(2):525–536
Gąssowska M, Baranowska-Bosiacka I, Moczydłowska J, Tarnowski M, Pilutin A, Gutowska I, Adamczyk A (2016) Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: relevance to neurological disorders. Toxicology 347:17–28
GoERING PL (1993) Lead-protein interactions as a basis for lead toxicity. Neurotoxicology 14(2):45–60
Green AJ, Planchart A (2018) The neurological toxicity of heavy metals: a fish perspective. Compar Biochem Physiol C Toxicol Pharmacol 208:12–19
Guilarte TR, McGlothan JL (1998) Selective decrease in NR1 subunit splice variant mRNA in the hippocampus of Pb2+-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes. Brain Res Mol Brain Res 56(1–2):151–157
Guilarte TR, Miceli RC (1992) Age-dependent effects of lead on the dopamine system and behavior in the rat. Brain Res 586(2):224–232
Guilarte TR, Toscano CD, McGlothan JL, Weaver SA (2003) Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure. Ann Neurol 53(1):50–56
Ha M, Kwon HJ, Lim MH, Jee YK, Hong YC, Leem JH, Jo SJ (2009) Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children’s health and environment research (CHEER). Neurotoxicology 30(1):31–36
Heo Y, Parsons PJ, Lawrence DA (1996) Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol 137(1):73–81
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3):65–87
Koller LD, Exon JH (2001) The immunotoxicity of environmental lead. Environ Health Perspect 109(Suppl 1):21–45
Lanphear BP, Hornung R, Khoury J et al (2005) Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect 113(7):894–899
Lee J, Freeman JL (2014) Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review. Neurotoxicology 43:57–64
Lee J, Freeman JL (2020) Exposure to the heavy-metal lead induces DNA copy number alterations in zebrafish cells. Chem Res Toxicol 33(8):2047–2053
Lepper TW, Oliveira E, Koch GDW, Berlese DB, Feksa LR (2010) Lead inhibits in vitro creatine kinase and pyruvate kinase activity in brain cortex of rats. Toxicol Vitro 24(3):1045–1051
Lidsky TI, Schneider JS (2003) Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126(1):5–19
Liu J et al (2013) Impact of low blood lead concentrations on IQ and school performance in Chinese children. PLoS ONE 8(5):e65230
Luster MI, Simeonova PP, Gallucci RM et al (1998) Role of inflammation in chemical-induced hepatotoxicity. Toxicol Appl Pharmacol 153(2):136
Maeda N, Shimizu S, Takahashi Y et al (2022) Oral exposure to lead acetate for 28 days reduces the number of neural progenitor cells but increases the number and synaptic plasticity of newborn granule cells in adult hippocampal neurogenesis of young-adult rats. Neurotox Res 40:2203–2220
Mason LH, Harp JP, Han DY (2014) Pb neurotoxicity: neuropsychological effects of lead toxicity. BioMed Res Int 2014:1–8
McElvania Tekippe E, Allen IC, Hulseberg PD et al (2018) Granulocyte/macrophage colony-stimulating factor (CSF) and CSF-1 receptor pathways cooperate in the differentiation of microglia into a unique intermediate stage. J Neuroinflamm 15(1):268
Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ (2007) Lead exposure and cardiovascular disease: a systematic review. Environ Health Perspect 115(3):472–482
Needleman HL (2004) Lead poisoning. Annu Rev Med 55:209–222
Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, Barrett P (1979) Deficits in psychologic and classroom performance of children with elevated dentine lead levels. New Engl J Med 300(13):689–695
Nemsadze K, Sanikidze T, Ratiani L, Gabunia L, Sharashenidze T (2009) Mechanisms of lead-induced poisoning. Georg Med News 172–173:92–96
Nigg JT, Knottnerus GM, Martel MM, Nikolas M, Cavanagh K, Karmaus W, Rappley MD (2008) Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biol Psych 63(3):325–331
Olung NF, Aluko OM, Jeje SO, Adeagbo AS, Ijomone OM (2021) Vascular dysfunction in the brain; implications for heavy metal exposures. Curr Hypertens Rev 17(1):5–13
Paithankar JG, Saini S, Dwivedi S, Sharma A, Chowdhuri DK (2021) Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction. Chemosphere 262:128350
Patrick L (2006a) Lead toxicity, a review of the literature. Part 1: exposure, evaluation, and treatment. Altern Med Rev. 11(1):2–22
Patrick L (2006b) Lead toxicity, a review of the literature Part 2: the clinical implications. Altern Med Rev 11(2):114–127
Patrick L (2006c) Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 11(2):1287
Raj K, Kaur P, Gupta GD, Singh S (2021) Metals associated neurodegeneration in Parkinson’s disease: insight to physiological, pathological mechanisms and management. Neurosci Lett 753:135873
Rice DC (2000) Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ Health Perspect 108(suppl 3):405–408
Rocha A, Trujillo KA (2019) Neurotoxicity of low-level lead exposure: History, mechanisms of action, and behavioral effects in humans and preclinical models. Neurotoxicology 73:58–80
Rosati E, Sabatini R, Rampino T et al (2021) Involvement of TLR4 and PPAR α receptors in hippocampal inflammation and oxidative stress following exposure to a high-fat diet and air pollution. Environ Pollut 268(Pt A):115918
Sanders T, Liu Y, Buchner V, Tchounwou PB (2009) Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health 24(1):15–46
Savolainen KM, Loikkanen J, Eerikäinen S, Naarala J (1998) Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead. Toxicol Lett 102:363–367
Shih RA, Hu H, Weisskopf MG, Schwartz BS (2007) Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115(3):483–492
Taiwo OA, Maroufi A, Bello OS (2018) Genotoxicity and potential carcinogenicity of lead: current perspectives and future directions. Front Public Health 6:254
Wang J, Feng W, Zhao Y et al (2015) Effects of lead exposure on T lymphocyte subsets and serum cytokines in workers. Biol Trace Elem Res 168(1):66–72
Wang SS, Xu X, Lu AX, Li WH, Liu JX, Liu C, Yan CH (2022) Amelioration of cholesterol sulfate for lead-induced CTX cell apoptosis based on BDNF signaling pathway mediated cholesterol metabolism. Ecotoxicol Environ Saf 248:114307
Wani AL, Ara A, Usmani JA (2015) Lead toxicity: a review. Interdiscip Toxicol 8(2):55–64
Winneke G (2011) Developmental aspects of environmental neurotoxicology: lessons from lead and polychlorinated biphenyls. J Neurol Sci 308(1–2):9–15
Wu YC, Lin YC, Yu HL, Chen JH, Chen TF, Sun Y (2020) Increased risk of Alzheimer’s disease in individuals with exposure to lead: a systematic review and meta-analysis. Sci Total Environ 707:135–213
Yang M, Li Y, Wang Y, Cheng N, Zhang Y, Pang S, Shen Q, Zhao L, Li G, Zhu G (2018) The effects of lead exposure on the expression of HMGB1 and HO-1 in rats and PC12 cells. Toxicol Lett 288:111–118
Yang L, Li X, Jiang A, Li X, Chang W, Chen J, Ye F (2020) Metformin alleviates lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells. Redox Biol 36:101626
Zhou R, Zhao J, Li D, Chen Y, Xiao Y, Fan A, Wang HL (2020) Combined exposure of lead and cadmium leads to the aggravated neurotoxicity through regulating the expression of histone deacetylase 2. Chemosphere 252:126589
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Singh, C., Singh, R., Shekhar, A. (2024). Effects of Lead: Neurological and Cellular Perspective. In: Kumar, N., Jha, A.K. (eds) Lead Toxicity Mitigation: Sustainable Nexus Approaches. Environmental Contamination Remediation and Management. Springer, Cham. https://doi.org/10.1007/978-3-031-46146-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-46146-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-46145-3
Online ISBN: 978-3-031-46146-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)